Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes

The epigenetic modifier EZH2 is part of the polycomb repressive complex that suppresses gene expression via histone methylation. Activating mutations in EZH2 are found in a subset of melanoma that contributes to disease progression by inactivating tumor suppressor genes. In this study we have target...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiffen, Jessamy C., Gunatilake, Dilini, Gallagher, Stuart J., Gowrishankar, Kavitha, Heinemann, Anja, Cullinane, Carleen, Dutton-Regester, Ken, Pupo, Gulietta M., Strbenac, Dario, Yang, Jean Y., Madore, Jason, Mann, Graham J., Hayward, Nicholas K., McArthur, Grant A., Filipp, Fabian V., Hersey, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694971/
https://www.ncbi.nlm.nih.gov/pubmed/26304929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694971/
https://www.ncbi.nlm.nih.gov/pubmed/26304929

Ejemplares similares